Psychedelics and schizophrenia: A mystery in history
Mark Haden, Birgitta Woods, Sarah A. Paschall
Journal of Psychedelic Studies December 2, 2023 DOI: 10.1556/2054.2023.00277 via OpenAlex
Summary
AI-generated from the abstractA review of current and historical research and clinical reports finds that the relationship between psychedelics and schizophrenia is complex, with some evidence that psychedelics may benefit this population. Specifically, lower doses of psychedelics, mostly LSD, appear to have a potential beneficial impact on the negative symptoms of schizophrenia.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Dose | lower doses |
| Keywords | Schizophrenia object-oriented programming Population Psychiatry Clinical psychology Medicine |
| Citations | 3 |
| Key finding | Lower doses of psychedelics, mostly LSD, appear to have a potential beneficial impact on the negative symptoms of schizophrenia. |
Abstract
Abstract This analysis of current and historical research and clinical reports observes that the relationship between psychedelics and schizophrenia is complex and there are reports of psychedelics benefiting this population. Specifically, lower doses of psychedelics (mostly LSD) appear to have a potential beneficial impact on the negative symptoms of schizophrenia.